Skip to main content

Table 2 Estimated number of true positives detected in average risk population. Number of true positives identified through FIT and MMT in the United States in adults aged 50–75 years, based on published estimates of CRC prevalence. The sensitivities for FIT (100 ng/mL cutoff) on advanced and non-advanced adenomas were 19.3 % and 11.2 %, respectively

From: Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions

Condition

Prevalence

Number of persons, aged 50–75 years, with conditiona

True positives identified by FIT

True positives identified by MMT

Cancer

0.3 %

241,483

181,112

221,359

Advanced adenoma

5.7 %

4,588,174

883,960

2,188,854

Non-advanced adenoma

17.7 %

14,247,488

1,600,841

6,723,534

  1. aNumber of persons in the United States in 2010 aged 50–75 years was 80,494,283